List view / Grid view

Imaging

 

Drug Target Review – Issue #1 2018

14 March 2018 | By

In this issue: how customised cell engineering advances immunotherapy, how insights into auto-immunity are providing new opportunities for immune-oncology, and advances in lab automation and robotics are accelerating the pace of antimicrobial therapy.

Send this to a friend